(Ϯ)-Rocaglamide and Its 2,3-Di-epi Analogue
8b-Hydroxy-6,8-dimethoxy-3a-(4-methoxyphenyl)-1-oxo-3-phenyl-
2,3,3a,8a-tetrahydrocyclopenta[b]benzofuran-2-nitrile (11): To the
reactant of metal Sm (1.50 g, 10 mmol) in a flame-dried, 100-mL,
three-necked round-bottom flask equipped with a stir bar, septum,
and nitrogen inlet was added a solution of C2H4I2 (1.41 g,
5.0 mmol) in THF (7 mL). After stirring for 1 h, the solution
changed to blue, and the reaction was continued for 3 h under ul-
trasound irradiation. Anhydrous benzene (20 mL) was then added,
and the reaction was continued for an additional 2 h. A solution
of 6c-1 (1.30 g, 2.6 mmol) in benzene (100 mL) was added, and the
reaction was allowed to proceed for 10 h under ultrasound irradia-
tion. The reaction was quenched with the addition of HCl (1 ,
20 mL), and the solution was extracted with CH2Cl2 (2ϫ30 mL).
The combined organic phase was washed with brine (2ϫ20 mL),
dried with anhydrous Na2SO4, and concentrated. The crude prod-
uct was purified by silica-gel column chromatography (petroleum
ether/EtOAc, 2:3) to afford 11 (0.28 g, 23.6%) as a white crystalline
to this solution was added NHMe2 (1.07 g, 23.8 mmol) and n-bu-
tyllithium (1.2 mL, 3 mmol)by syringe. After stirring for 20 min, a
solution of 7a (0.15 g, 0.31 mmol) in THF (6 mL) was added by
syringe, and the reaction was continued at –78 °C for 30 min. The
cold bath was then removed, and the reaction mixture was allowed
to stir at room temperature for an additional 1 h. The reaction was
quenched by the addition of CH3OH (2 mL), and aqueous HCl
(1 , 15 mL) was then added dropwise slowly. The mixture was
extracted with CH2Cl2 (4 ϫ 15 mL), and the combined organic
phase was washed with brine (3ϫ10 mL), dried with Na2SO4, and
concentrated. The crude product was purified by silica-gel column
chromatography (petroleum ether/EtOAc, 2:3) to afford 8a (0.13 g,
84.4%) as a white crystalline solid. M.p. 143–144 °C. 1H NMR
(300 MHz, CDCl3, 25 °C): δ = 2.90 (s, 3 H, CH3N), 3.01 (br. s, 1
H, 8b-OH), 3.25 (s, 3 H, CH3N), 3.73 (s, 3 H, CH3O), 3.80 (s, 3
3
H, CH3O), 3.84 (s, 3 H, CH3O), 4.33 (d, JH,H = 13.2 Hz, 1 H, 3-
3
4
H), 4.51 (d, JH,H = 13.2 Hz, 1 H, 2-H), 6.08(d, JH,H = 1.8 Hz, 1
1
4
solid. M.p. 190–191 °C. H NMR (300 MHz, [D6]DMSO, 25 °C):
H, C6H1), 6.32 (d, JH,H = 1.8 Hz, 1 H, C6H1), 6.70–6.73 (m, 2 H,
δ = 3.60 (s, 3 H, CH3O), 3.74 (s, 3 H, CH3O), 3.77 (s, 3 H, CH3O),
C6H2), 6.82–6.85 (m, 2 H, C6H2), 6.98–7.01 (m, 2 H, C6H2), 7.07–
4
4.50 (s, 1 H, 3-H), 5.64 (d, JH,H = 1.8 Hz, 1 H, C6H1), 5.88 (s, 1 7.09 (m, 3 H, C6H3) ppm. 13C NMR (75 MHz, CDCl3, 25 °C): δ
4
H, 8b-OH, disappeared after D2O exchange), 6.06 (d, JH,H
=
= 205.7, 165.3, 164.8, 161.1, 158.9, 158.5, 136.2, 128.0, 127.9, 126.9,
3
1.8 Hz, 1 H, C6H1), 6.73–6.76 (m, 2 H, C6H2), 6.93–6.96 (d, JH,H 126.1, 113.2, 106.2, 99.3, 93.0, 89.9, 88.6, 55.6, 55.1, 53.9, 52.0,
3
= 9.0 Hz, 2 H, C6H2), 7.12–7.15 (m, 3 H, C6H3), 7.36 (d, JH,H
=
37.7, 36.2 ppm. MS (EI): m/z (%) = 485 (25.3) [M]+, 458 (2), 414
9.0 Hz, 2 H, C6H2), 11.33 (s, 1 H, 1-OH, disappeared after D2O
exchange) ppm.
(8), 300 (100), 285 (19.3), 176 (3.3), 131 (7.3), 103 (3.3), 72 (5.0).
Following the same procedure, 8b (0.13 g, 81.8%) was prepared
from 7b (0.15 g, 0.31 mmol). M.p. 209–210 °C. 1H NMR
(300 MHz, CDCl3, 25 °C): δ = 2.96 (s, 6 H, Me2N), 3.47 (s, 1 H,
8b-OH), 3.77 (s, 3 H, CH3O), 3.78 (s, 3 H, CH3O), 3.80 (m, 3 H,
Methyl 8b-Hydroxy-6,8-dimethoxy-3a-(4-methoxyphenyl)-1-oxo-3-
phenyl-2,3,3a,8a-tetrahydrocyclopenta[b]benzofuran-2-carboxylate
(7): Prepared from 6d-1 by a similar procedure to that used for 11
to afford 7a (0.68 g, 53.7%) as a white crystalline solid. M.p. 163–
164 °C (keto form) (ref.[4d] 87.5–89.5 °C as keto/enol, 65:35). 1H
NMR (300 MHz, CDCl3, 25 °C): δ = 3.04 (s, 1 H, 8b-OH, disap-
peared after D2O exchange), 3.66 (s, 3 H, CH3O), 3.71 (s, 3 H,
3
3
CH3O), 4.54 (d, JH,H = 13.2 Hz, 1 H, 3-H), 4.75 (d, JH,H
=
4
13.2 Hz, 1 H, 2-H), 6.03 (d, JH,H = 1.8 Hz, 1 H, C6H1), 6.16 (d,
4JH,H = 1.8 Hz, 1 H, C6H1), 6.87 (d, JH,H = 9.0 Hz, 2 H, C6H2),
3
7.03–7.06 (m, 2 H, C6H2), 7.17–7.20 (m, 3 H, C6H3), 7.37 (d, 3JH,H
= 9.0 Hz, 2 H, C6H2) ppm. 13C NMR (75 MHz, CDCl3, 25 °C): δ
= 204.8, 166.3, 164.5, 162.0, 159.2, 158.1, 135.2, 128.9, 128.8, 128.2,
128.0, 127.3, 113.3, 104.8, 97.5, 92.5, 88.6, 87.0, 55.7, 55.6, 55.2,
54.0, 52.3, 37.0, 35.9 ppm. MS (EI): m/z (%) = 485 (3.3) [M]+, 300
(100), 285 (20.0), 242 (2.3), 176 (5.3), 131 (12.0), 103 (8.0), 72
(12.0), 44 (6.0).
3
CH3O), 3.81 (s, 3 H, CH3O), 3.85 (s, 3 H, CH3O), 4.06 (d, JH,H
= 13.2 Hz, 1 H, 3-H), 4.24 (d, 3JH,H = 13.2 Hz, 1 H, 2-H), 6.10 (d,
4
4JH,H = 1.8 Hz, 1 H, C6H1), 6.35 (d, JH,H = 1.8 Hz, 1 H, C6H1),
6.66–6.70 (m, 2 H, C6H2), 6.89–6.97 (m, 4 H, C6H4), 7.08–7.12 (m,
3 H, C6H3) ppm. 13C NMR (75 MHz, CDCl3 + D2O, 25 °C): δ =
203.3, 167.2, 164.9, 161.0, 158.9, 158.6, 135.4, 129.1, 128.0, 127.9,
127.7, 127.1, 125.4, 113.2, 112.2, 106.1, 99.3, 92.9, 89.9, 88.5, 56.4,
55.7, 55.6, 55.1, 55.0, 52.9, 52.0, 51.5 ppm. MS (EI): m/z (%) = 472
(6.0), 414 (4.6), 300 (100), 285 (26.6), 269 (3.0), 242 (3.0), 135
(10.0), 104 (3.0), 77 (3.0), 44 (7.3).
1,8b-Dihydroxy-6,8-dimethoxy-3a-(4-methoxyphenyl)-N,N-dimeth-
yl-3-phenyl-2,3,3a,8b-tetrahydrocyclopenta[b]benzofuran-2(1H)-
carboxamide (؎)-1 and (؎)-3: Under a N2 atmosphere, a mixture of
Me4NBH(OAc)3 (0.45 g, 1.71 mmol), CH3CN (1 mL), and HOAc
(1 mL) was stirred at room temperature for 0.5 h, and then a solu-
tion of 8a (0.12 g, 0.24 mmol) in CH3CN (2.5 mL) was added by
syringe. The reaction mixture was stirred at room temperature for
an additional 24 h. The reaction was quenched with a saturated
solution of NaHCO3 (50 mL), and the solution was then extracted
with CH2Cl2 (4ϫ5 mL). The combined organic phase was washed
with brine, dried with Na2SO4, and concentrated. The crude prod-
uct was purified by silica-gel column chromatography (petroleum
ether/EtOAc, 1:4) to afford (Ϯ)-1 (0.105 g, 87.2%) as a white crys-
talline solid. M.p. 120–122 °C (ref.[4d] 119–120 °C). 1H NMR
(300 MHz, CDCl3, 25 °C): δ = 2.94 (s, 3 H, CH3N), 3.31 (s, 3 H,
CH3N), 3.70 (s, 3 H, CH3O), 3.83 (s, 3 H, CH3O), 3.85 (s, 3 H,
Following the same procedure, 7b (0.64 g, 50.2%) was obtained
1
from 6d-2. M.p. 95–96 °C. H NMR (300 MHz, CDCl3, 25 °C): δ
= 3.52 (br. s, 1 H, 8b-OH), 3.62 (d, 3JH,H = 6.3 Hz, 1 H, 3-H), 3.70
(s, 3 H, CH3O), 3.75 (s, 3 H, CH3O), 3.78 (s, 3 H, CH3O), 3.80 (s,
3
4
3 H, CH3O), 4.40 (d, JH,H = 6.3 Hz, 1 H, 2-H), 6.01 (d, JH,H
=
4
2.1 Hz, 1 H, C6H1), 6.14 (d, JH,H = 2.1 Hz, 1 H, C6H1), 6.89 (d,
3JH,H = 8.5 Hz, 2 H, C6H2), 7.03–7.06 (m, 2 H, C6H2), 7.19–7.23
(m, 3 H, C6H3), 7.34 (d, JH,H = 8.5 Hz, 2 H, C6H2) ppm. 13C
3
NMR (75 MHz, CDCl3, 25 °C): δ = 203.2, 168.3, 164.7, 163.8,
161.9, 159.4, 159.3, 158.2, 134.0, 130.4, 128.9, 128.7, 128.3, 128.2,
128.1, 127.7, 127.6, 127.4, 127.3, 126.6, 113.5, 113.4, 104.1, 97.2,
92.5, 92.3, 88.4, 88.2, 88.1, 86.8, 55.7, 55.2, 54.8, 54.3, 52.6 ppm.
MS (EI): m/z (%) = 472 (13.3), 458 (2.0), 414 (12.7), 399 (2.0), 300
(100), 285 (27.3), 269 (4.0), 242 (3.0), 181 (2.0), 135 (10.0), 121
(3.0), 103 (4.0), 77 (4.0).
3
3
CH3O), 4.05 (dd, JH,H = 13.5 Hz, JH,H = 6.5 Hz, 1 H, 2-H), 4.55
3
3
(d, JH,H = 13.5 Hz, 1 H, 3-H), 4.93 (d, JH,H = 6.5 Hz, 1 H, 1-H),
4
4
6.10 (d, JH,H = 1.8 Hz, 1 H, C6H1), 6.27 (d, JH,H = 1.8 Hz, 1 H,
C6H1), 6.65–6.70 (m, 2 H, C6H2), 6.84–6.87 (m, 2 H, C6H2), 7.01–
7.13 (m, 5 H, C6H5) ppm. 13C NMR (75 MHz, CDCl3, 25 °C): δ
= 169.6, 163.9, 161.1, 158.6, 157.3, 137.6, 128.9, 127.8, 127.7, 127.1,
126.3, 112.7, 107.6, 101.7, 94.1, 92.5, 89.3, 78.6, 56.0,55.7, 55.1,
47.6, 37.0, 35.8 ppm. MS (EI): m/z (%) = 505 (12.0) [M]+, 487
(10.0), 442 (5.3), 416 (19.3), 390 (60.7), 368 (4.7), 325 (4.0), 313
8b-Hydroxy-6,8-dimethoxy-3a-(4-methoxyphenyl)-N,N-dimethyl-1-
oxo-3-phenyl-2,3,3a,8a-tetrahydrocyclopenta[b]benzofuran-2-carbox-
amide (8): THF (8 mL) in a flame-dried, 50-mL, three-neck, round-
bottomed flask equipped with a stir bar, thermometer, septum, and
nitrogen inlet was cooled to –78 °C in a dry ice/acetone bath, and
Eur. J. Org. Chem. 2008, 1753–1758
© 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
1757